CD8A and breast cancer: CD8+ T cells in breast cancer are predominantly of the effector memory cell subtype, with cytotoxic capacity mediating antitumor immunity, but with the ability to secrete proinflammatory cytokines IL-2, TNFα, and INFγ as well [86,113].